UBS AM
FURX

UBS AM’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

UBS AM’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,700
Closed -$393K – 2613
2014
Q2 		$393K Buy
3,700
+300
+9% +$29.4K ﹤0.01% 2022
2014
Q1 		$296K Buy
+3,400
New +$262K ﹤0.01% 2185

UBS AM's FURX Position: Q3 2014 in Review

UBS AM sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 3,700 shares — an estimated $393K sold.

UBS AM first reported a position in FURX in Q1 2014 and held it in 2 quarters. The position peaked at $393K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • UBS AM reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • UBS AM sold 3,700 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $393K.
  • UBS AM first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • UBS AM's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $393K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.